Effects of fenfluramine and phentermine (fen-phen) on dopamine and serotonin release in rat striatum: In vivo microdialysis study in conscious animals

Brain Research

Volumn 813, Issue 1, 1998, Pages 67-72

  Balcioglu, Aygul ^a   Wurtman, Richard J ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Dopamine; Fenfluramine; Phentermine; Serotonin; Striatum

Indexed keywords

DOPAMINE; FENFLURAMINE; PHENTERMINE; SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; CONSCIOUSNESS; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE;

ANALYSIS OF VARIANCE; ANIMALS; APPETITE DEPRESSANTS; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; FENFLURAMINE; MALE; MICRODIALYSIS; PHENTERMINE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN;

EID: 0032583262     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)01003-8     Document Type: Article

References (36)

1. Balcioglu A., Wurtman R.J. Effects of phentermine on striatal dopamine and serotonin release in conscious rats: in vivo microdialysis study. Int. J. Obes. 22:1998;325-328.
2. Balcioglu A., Wurtman R.J. Dexfenfluramine enhances striatal dopamine release in conscious rats via a serotoninergic mechanism. J. Pharm. Exp. Ther. 283:1998;991-997.
3. Bauman M.H., Rothman R.B. Combined phentermine/fenfluramine administration and central serotonin neurons. Synapse. 28:1998;339-942.
4. Beckett A.H., Belanger P.M. The microsomal N-oxidation of phentermine. J. Pharm. Pharmacol. 28:1976;692-699.
5. Benloucif S., Galloway M.P. Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis. Eur. J. Pharmacol. 200:1991;1-8.
6. Benloucif S., Keegan M.J., Gallaway M.P. Serotonin-facilitated dopamine release in vivo. Pharmacological characterization. J. Pharmacol. Exp. Ther. 265:1993;373-377.
7. Benveniste H., Drejer J., Shousbrou A., Diemer N.H. Regional cerebral glucose phosphorylation and blood flow after insertion of a microdialysis fibre through the dorsal hippocampus in the rat. J. Neurochem. 49:1987;729-734.
8. Bettini E., Ceci A., Spinelli R., Samanin R. Neuroleptic-like effects of the L-isomer of fenfluramine on striatal dopamine release in freely moving rats. Biochem. Pharmacol. 36:1987;2387-2391.
9. Bonhomme N., De Deurwaerdere N.P., Le Moal M., Spampinato U. Evidence for 5-HT4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: a microdialysis study in the halothane-anesthetized rat. Neuropharmacology. 34:1995;269-279.
10. Chen J., van Praag H.M., Gardner E.L. Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens. Brain Res. 543:1991;354-357.
11. Dobrzanski S., Doggett N.S. The effect of propranolol, phentolamine and pimozide on drug-induced anorexia in the mouse. Psychopharmacology. 66:1979;297-300.
12. Ferre S., Artigas F. Dopamine D2 receptor-mediated regulation of serotonin extracellular concentration in the dorsal raphe nucleus of freely moving rats. J. Neurochem. 61:1993;772-775.
13. Galloway M.P., Suchowski C.S., Keegan M.J., Hjorth S. Local infusion of the selective 5-HT1b agonist CP-93,129 facilitates striatal dopamine release in vivo. Synapse. 15:1993;90-92.
14. S. Garattini, E. Borroni, T. Mennini, R. Samanin, Differences and similarities among anorectic agents, in: S. Garattini, R. Samanin (Ed.), Central Mechanisms of Anorectic Drugs, Raven Press, New York, 1978, pp. 127-141.
15. S. Garattini, R. Samanin, Anorectic drugs and brain neurotransmitters, in: T. Silverstone (Ed.), Dahlem Workshop on Appetite and Food Intake, Abakon, Berlin, 1976, pp. 83-108.
16. Garattini S., Bizzi A., Codegoni A.M., Caccia S., Mennini T. Progress report on the anorexia induced by drugs believed to mimic some of the effects of serotonin on the central nervous system. Am. J. Clin. Nutr. 55:1992;160S-166S.
17. Giambalvo C.T., Snodgrass S.T. Biochemical and behavioral effects of serotonin neurotoxins on the nigro-striatal dopamine system: comparison of injection sites. Brain Res. 152:1978;555-556.
18. Gudelsky G.A., Nash J.F. Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions. J. Neurochem. 66:1996;243-249.
19. Matsumoto M., Yoshioka M., Togashi H., Saito H. Dopamine receptor regulation of serotonin release from the rat hippocampus measured by in vivo microdialysis. J. Neurochem. 65:1995;S29.
20. Mendlin A., Martin F.J., Reeves A.J., Jacobs B.L. Systemic administration of the dopamine agonist apomorphine increases serotonin release in rat forebrain. Soc. Neu. Abst. 23:1997;1227.
21. Moghaddam B., Bunney B.S. Ionic composition of microdialysis perfusing solution alters the pharmacological responsiveness and basal outflow of striatal dopamine. J. Neurochem. 53:1989;652-654.
22. Osborne N.N., Neuhall V., Sontag K.H., Wolfarth S. A preliminary study on the behavior and biochemical responses subsequent to the injection of 5,6-dihydroxytryptamine into the substantia nigra of the rat. Experientia. 34:1978;495-496.
23. Parsons L.H., Justice J.B. Jr. Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res. 606:1993;195-199.
24. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, 2nd edn., Academic Press, Sydney, 1986.
25. Pinder R.M., Brogden R.N., Sawyer P.R., Speight T.M., Avery G.S. Fenfluramine: a review. A review of its pharmacological properties and therapeutic efficacy in obesity. Drugs. 10:1975;241-323.
26. Robinson T.E., Camp D.M. The effect of four days of continuous striatal microdialysis on indices of dopamine and serotonin neurotransmission in rats. J. Neurosci. Methods. 40:1991;211-222.
27. Samanin R., Ghezzi D., Valzelli L., Garattini S. The effect of selective lesioning of brain serotonin or catecholamine containing neurons on the anorectic activity of fenfluramine and amphetamine. Eur. J. Pharmacol. 19:1972;318-322.
28. Samanin R., Bernasconi S., Garattini S. The effect of selective lesioning of brain catecholamine-containing neurons on the activity of various anorectics in the rat. Eur. J. Pharmacol. 34:1975;373-375.
29. Shoaib M., Baumann M.H., Rothman R.B., Goldberg S.R., Schindler C.W. Behavioural and neurochemical characteristics of phentermine and fenfluramine administered separately and as a mixture in rats. Psychopharmacology. 131:1997;296-306.
30. Spedding M., Ouvry C., Millan M., Duhault J., Dacquet C., Wurtman R. Neural control of dieting. Nature. 380:1996;488.
31. Steinbusch H.V., Van Der Kooy D., Verhofstad A.A., Pellegrino A. Serotoninergic and non-serotoninergic projections from nucleus raphe dorsalis to the caudate putamen complex in the rat, studied by a combined immunofluorescence and fluorescent retrograde axonal labeling technique. Neurosci. Lett. 19:1980;137-142.
32. Tossman U., Ungerstedt U. Microdialysis in the study of extracellular levels of aminoacids in the rat brain. Acta Physiol. Scand. 128:1986;9-14.
33. Van Bockstaele E.J., Pickel V.M. Ultrastructure of serotonin-immunoreactive terminals in the core and shell of the rat nucleus accumbens: cellular substrates for interactions with catecholamine afferents. J. Comp. Neurol. 334:1993;603-617.
34. Van Der Kooy D., Hattori T. Dorsal raphe cells with collateral projections to the caudate-putamen and substantia nigra: a fluorescent retrograde double labelling study in the rat. Brain Res. 186:1980;1-7.
35. Weintraub M., Hasday J.D., Mushlin A.I., Lockwood D.H. A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination. Arc. Int. Med. 144:1984;1143-1148.
36. Weintraub M., Sundaresan P.R., Madan M., Schuster B., Balder A., Lasagna L., Cox C. Long-term weight control study. I (weeks 0 to 34). The enhancement of behavior modification, caloric restriction, and exercise by fenfluramine plus phentermine versus placebo. Clin. Pharmacol. Ther. 51:1992;586-594.